Sascha Haverfield

Sascha Haverfield currently serves as the Head of Portfolio Strategy and Operations for the Oncology TAU at Takeda Oncology, where strategic alignment of the R&D portfolio and agile execution of asset strategies are paramount. Previous roles at Takeda included oversight of New Product Planning and leadership in Regulatory Affairs for the Plasma-derived Therapies Business Unit. Notably, during tenure at Shire, Sascha held the position of Group Vice President, leading global regulatory strategies across multiple therapeutic areas. A seasoned professional in regulatory affairs, Sascha's earlier experience includes impactful roles at PhRMA, Abbott Laboratories, and deCODE genetics, coupled with a strong academic background featuring a Doctorate from the University of Oxford.